H.Y. Meltzer
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 0.5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Schizophrenia research and treatment 26
- Electroconvulsive Therapy Studies 13
- Bipolar Disorder and Treatment 11
-
- Tryptophan and brain disorders 5
- Co-authors
- Stephen M. StahlLynne E. WayPaul A. ThompsonRolando Gutierrez-EsteinouMizuho HasegawaJack P. AntelM T LowyM. Simonovic
- Journals
- Schizophrenia Research (13 papers)American Journal of Psychiatry (8 papers)Neuropsychopharmacology (4 papers)European Neuropsychopharmacology (4 papers)Schizophrenia Bulletin (3 papers)
- Partner nations
- United StatesCanadaCroatia
In The Last Decade
H.Y. Meltzer
62 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Biological Psychiatry 368
- Psychiatry and Mental health 1.9k
- Behavioral Neuroscience 240
- Cellular and Molecular Neuroscience 1.1k
- Philosophy 362
Countries citing papers authored by H.Y. Meltzer
This map shows the geographic impact of H.Y. Meltzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.Y. Meltzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.Y. Meltzer more than expected).
Fields of papers citing papers by H.Y. Meltzer
This network shows the impact of papers produced by H.Y. Meltzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.Y. Meltzer. The network helps show where H.Y. Meltzer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H.Y. Meltzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 25 | |
| 2 | 2014 | 23 | |
| 3 | 2013 | 29 | |
| 4 | 2012 | 91 | |
| 5 | 2003 | 131 | |
| 6 | Preliminary evidence that neuronal and glial density is increased and neuronal size is decreased in hippocampus in major depressive disorder | 2002 | 1 |
| 7 | 2000 | 8 | |
| 8 | 1998 | 3 | |
| 9 | 1996 | 91 | |
| 10 | 1995 | 42 | |
| 11 | 1995 | 64 | |
| 12 | 1993 | 150 | |
| 13 | 1993 | 2 | |
| 14 | 1991 | 3 | |
| 15 | 1990 | 65 | |
| 16 | 1988 | 21 | |
| 17 | 1984 | 41 | |
| 18 | Repeated administration of drugs known to inhibit the activity of serotonergic neurons potentiates the prolactin-releasing effect of serotonin agonists | 1981 | 1 |
| 19 | Effect of neuroleptic drugs on platelet monoamine oxidase activity | 1981 | 4 |
| 20 | 1953 | 1 |
About H.Y. Meltzer
H.Y. Meltzer is a scholar working on Psychiatry and Mental health, Biological Psychiatry, Behavioral Neuroscience, Cellular and Molecular Neuroscience and Philosophy, having authored 67 papers that have together received 3.4k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (26 papers), Neurotransmitter Receptor Influence on Behavior (13 papers), Electroconvulsive Therapy Studies (13 papers), Bipolar Disorder and Treatment (11 papers), Stress Responses and Cortisol (6 papers), Mental Health and Psychiatry (6 papers), Tryptophan and brain disorders (5 papers) and Receptor Mechanisms and Signaling (5 papers). The work is most often cited by research in Biological Psychiatry (368 citations), Psychiatry and Mental health (1.9k citations), Behavioral Neuroscience (240 citations), Cellular and Molecular Neuroscience (1.1k citations) and Philosophy (362 citations). H.Y. Meltzer has collaborated with scholars based in United States, Canada and Croatia. Frequent co-authors include Stephen M. Stahl, Lynne E. Way, Paul A. Thompson, Rolando Gutierrez-Esteinou, Mizuho Hasegawa, Jack P. Antel, M T Lowy, M. Simonovic, Philip A. Cola and Jiro Ichikawa. Their work appears in journals such as Schizophrenia Research, American Journal of Psychiatry, Neuropsychopharmacology, European Neuropsychopharmacology and Schizophrenia Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.